← Back to All Filings

West Pharmaceutical Services Insider Exercises Options and Sells $2.77M in Stock

Medium SignificanceSeptember 10, 2026 at 10:07:26 PM UTC

WEST PHARMACEUTICAL SERVICES INC

$WST4CIK: 0000105770

Subscribe to track WST

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

📊 Insider Trade Alert: WEST PHARMACEUTICAL SERVICES INC ($WST)

Insider: Favorite Annette F (Sr. VP & Chief HR Officer) Transaction: Option Exercise & Sale Shares Transacted: 8,135 shares sold @ $340.81 (weighted avg) Total Sale Value: $2,772,489.35 Remaining Holdings: 16,844.55 shares Filing Date: 2026-09-10

Comprehensive Analysis

Executive Summary

On September 8, 2026, Annette F. Favorite, Senior Vice President & Chief HR Officer of West Pharmaceutical Services, Inc. ($WST), executed a series of option exercises and same-day open-market sales. In total, 8,135 shares were acquired via stock option exercises at strike prices of $83.47 and $89.64, and subsequently sold at a weighted average price of $340.81 per share, generating aggregate gross sale proceeds of approximately $2.77 million.

Transaction Breakdown

  • Option Exercises (Code M):

    • 2,817 shares at an exercise price of $83.47 per share
    • 2,818 shares at an exercise price of $83.47 per share
    • 2,500 shares at an exercise price of $89.64 per share
    • Total Option Exercise Cost: $694,453.45
  • Open Market Sales (Code S):

    • 8,135 total shares sold at a weighted average price of $340.81 per share
    • Total Gross Sale Proceeds: $2,772,489.35
    • Net Realized Gain (pre-tax): ~$2,078,035.90

Post-Transaction Holdings

Following the transactions, Annette Favorite directly holds 16,844.5548 shares of West Pharmaceutical Services Common Stock, alongside 7,524 remaining vested options exercisable at $89.64 expiring in February 2028.

Topics:#WST#WestPharma#InsiderTrading#StockMarket#SEC

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.